SCHEMBL1347744

SCHEMBL1347744

NC(=O)c1cccc(-c2ccc(CNCCC3CCCCC3)c(F)c2)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.44
HDAC6 Q9UBN7 3/20 0.43
TRPA1 O75762 1/20 0.43
EPHX2 P34913 1/20 0.43
FAAH2 Q6GMR7 1/20 0.43
MGLL Q99685 1/20 0.43
CTSC P53634 4/20 0.43
CTSK P43235 3/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
ERN1 O75460 1/20 0.42
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
F2RL1 P55085 1/20 0.41
DPP4 P27487 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1345865 0.88 FAAH (0.44) FAAHHDAC6TRPA1EPHX2FAAH2
SCHEMBL1347281 0.88 FAAH (0.43) FAAHHDAC6TRPA1EPHX2FAAH2
SCHEMBL1348267 0.85 MEN1 (0.48) FAAHHDAC6TRPA1EPHX2FAAH2
SCHEMBL1347674 0.84 OPRM1 (0.48) FAAHHDAC6TRPA1EPHX2FAAH2
SCHEMBL1788268 0.82 PARP10 (0.41) HDAC6CTSCCTSKMEN1KMT2A
SCHEMBL1348140 0.82 FAAH (0.45) FAAHHDAC6TRPA1EPHX2FAAH2
Trifluoroacetic Acid SCHEMBL3343134 0.82 HTR5A (0.47) FAAHHDAC6TRPA1EPHX2FAAH2
Hydrochloric Acid SCHEMBL3338546 0.81 PARP10 (0.40) HDAC6CTSCCTSKERN1HDAC3
SCHEMBL1345801 0.80 HDAC6 (0.43) FAAHHDAC6TRPA1EPHX2FAAH2
SCHEMBL1347716 0.79 SIGMAR1 (0.50) FAAHHDAC6TRPA1EPHX2FAAH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8063247-B2 Bicyclic aryl and heteroaryl receptor modulators PROSIDION LIMITED (GB) 2011-11-22 US claimed
US-8063247-B2 Bicyclic aryl and heteroaryl receptor modulators PROSIDION LIMITED (GB) 2011-11-22 US disclosed
US-8063247-B2 Bicyclic aryl and heteroaryl receptor modulators PROSIDION LIMITED (GB) 2011-11-22 US disclosed
US-8063247-B2 Bicyclic aryl and heteroaryl receptor modulators PROSIDION LIMITED (GB) 2011-11-22 US disclosed
US-20100267780-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS PROSIDION LIMITED (GB) 2010-10-21 US disclosed
US-20100267780-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS PROSIDION LIMITED (GB) 2010-10-21 US disclosed
US-20100267780-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS PROSIDION LIMITED (GB) 2010-10-21 US disclosed
WO-2009030962-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS PROSIDION LIMITED (GB) 2009-03-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267780-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS OPRM1, OPRL1, OPRD1 FAAH 224/4885HDAC6 752/4885TRPA1 312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.